SCHEMBL31017571

SCHEMBL31017571

Cc1cc([N+](=O)[O-])c(OC(C)C)cc1C1=CCNCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR6 P50406 6/20 0.41
▸ ALK Q9UM73 2/20 0.41
▸ HTR2A P28223 1/20 0.39
▸ PDK1 Q15118 1/20 0.36
▸ HTR2C P28335 2/20 0.33
▸ MEN1 O00255 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ ALDH1A1 P00352 1/20 0.33
▸ CYP1A2 P05177 1/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ MAPT P10636 1/20 0.33
▸ HTR1D P28221 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ BRCA1 P38398 1/20 0.33
▸ HSD17B10 Q99714 1/20 0.33
▸ QDPR P09417 1/20 0.33
▸ PRMT5 O14744 1/20 0.33
▸ TGFBR1 P36897 1/20 0.32
▸ ACVR1 Q04771 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19556801 1.00 HTR6 (0.41) HTR6ALKHTR2APDK1HTR2C
Tert-Butyl Formate SCHEMBL27788187 0.90 ALK (0.38) HTR6ALKHTR2APDK1HTR2C
SCHEMBL19174976 0.87 HTR6 (0.43) HTR6ALKHTR2AHTR2CMEN1
SCHEMBL17879591 0.87 HTR6 (0.39) HTR6ALKHTR2AHTR2CMEN1
SCHEMBL17304107 0.83 HTR6 (0.43) HTR6ALKHTR2AHTR2CMEN1
SCHEMBL30640822 0.83 HTR6 (0.43) HTR6ALKHTR2AHTR2CMEN1
SCHEMBL19557720 0.81 HTR6 (0.39) HTR6ALKHTR2AHTR2CMEN1
SCHEMBL17304117 0.80 BRD4 (0.41) HTR6ALKHTR2AHTR2CMEN1
SCHEMBL26041932 0.80 HTR6 (0.39) HTR6ALKHTR2AHTR2CMEN1
SCHEMBL1545612 0.80 PDK1 (0.37) PDK1XDH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118355012-A Novel heterocyclic substituted pyrimidine derivative exhibiting cancer cell growth inhibitory effect and pharmaceutical composition containing the same 昂科比克斯有限公司 2024-07-16 — — CN disclosed
Send feedback